These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17265807)

  • 21. Blood ties: accountability for blood quality in New Zealand.
    Howden-Chapman P
    Health Policy; 1994 Jan; 27(1):35-51. PubMed ID: 10133135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safe blood transfusion practices.
    Bharucha ZS
    Indian J Pediatr; 2001 Feb; 68(2):127-31. PubMed ID: 11284180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Hemovigilance Commission of the University Hospital Center].
    Baudoux E; Blaffart F; Bouffioux C; Caprasse M; Courtois F; Cremasco MR; De Pasqual E; Fassotte MF; Gillet P; Lamy M; Larbuisson R; Lemaire R; Merciny M; Moutschen M; Radermecker M; Remy B; Sondag D
    Rev Med Liege; 2000 Sep; 55(9):878-80. PubMed ID: 11105604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Governance in the European union: the European Blood Directive as an evolving practice.
    Hansen-Magnusson H
    Clin Lab Med; 2010 Jun; 30(2):489-97. PubMed ID: 20513566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 26. Repeat voluntary non-remunerated blood donor is the best quality indicator for blood safety.
    Nair SC; Mammen JJ
    Indian J Med Res; 2015 Jun; 141(6):749-52. PubMed ID: 26205016
    [No Abstract]   [Full Text] [Related]  

  • 27. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
    Diekamp U; Wehrend W; Marklof E; Kamutzky K
    Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States.
    Vamvakas EC; Kleinman S; Hume H; Sher GD
    Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ISBT Board response to the Dublin consensus statement.
    Flanagan P
    Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536
    [No Abstract]   [Full Text] [Related]  

  • 30. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rethinking blood shield statutes in view of the hepatitis C pandemic and other emerging threats to the blood supply.
    Rueda A
    J Health Law; 2001; 34(3):419-58. PubMed ID: 11571894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tools for improving quality in the transfusion service.
    Berte LM
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S36-42. PubMed ID: 9124228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safer haemotherapy: the responsibilities of government, transfusion service, blood donors, and physician-users.
    Moore BP
    Haematologia (Budap); 1995; 27(1):39-45. PubMed ID: 12051295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of the blood supply.
    Sloand EM; Pitt E; Klein HG
    JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood safety--at what cost?
    Bekker LG; Wood R
    JAMA; 2006 Feb; 295(5):557-8. PubMed ID: 16449622
    [No Abstract]   [Full Text] [Related]  

  • 36. [Judicial liability and blood transfusion--equity, opportunity?].
    Hermitte MA
    Transfus Clin Biol; 1997; 4(3):321-8. PubMed ID: 9264790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What are the rules and regulations for blood product transfusion in France?].
    Pélissier E; Bierling P
    Rev Prat; 2009 Jan; 59(1):90-2. PubMed ID: 19253890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunobiology--the neglected side of transfusion].
    Flesland O; Solheim BG
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981
    [No Abstract]   [Full Text] [Related]  

  • 40. [Situation and perspectives of blood transfusion in Togo].
    Ségbéna AY; Fétéké L; Bikandou B; Awitala EJ; Koura AG
    Transfus Clin Biol; 2009; 16(5-6):460-3. PubMed ID: 19896405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.